Literature DB >> 28005146

[Diagnostics of drug hypersensitivity reactions].

C Möbs1, W Pfützner2.   

Abstract

Drug hypersensitivity reactions comprise approximately 25% of all adverse drug reactions and can be classified into allergic and pseudoallergic drug reactions. Immediate type anaphylactic and delayed type rash reactions of various clinical patterns can be distinguished, depending on the pathogenesis and clinical symptoms. The diagnostic work-up encompasses a thorough but also focused evaluation of the medical history, skin tests and when indicated challenge tests. Furthermore, in vitro tests, such as basophil activation tests and T cell assays not only add valuable additional information but can also yield decisive results for the diagnosis, especially in cases of severe drug reactions or reactions which cannot be further clarified by provocation tests. The aim of these measurements is not only the proof of drug intolerance and the detection of the causal drug but also the disclosure of the type of adverse reaction and the identification of potential, tolerated alternative drugs. This information is very important for the counseling of the patient and for prevention of new drug hypersensitivity reactions in the future.

Entities:  

Keywords:  Basophils; Drug challenge test; In vitro tests; Prevention; T lymphocytes

Mesh:

Year:  2017        PMID: 28005146     DOI: 10.1007/s00105-016-3908-x

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  37 in total

1.  General considerations for skin test procedures in the diagnosis of drug hypersensitivity.

Authors:  K Brockow; A Romano; M Blanca; J Ring; W Pichler; P Demoly
Journal:  Allergy       Date:  2002-01       Impact factor: 13.146

2.  Increased sensitivity of patch testing by standardized tape stripping beforehand: a multicentre diagnostic accuracy study.

Authors:  Heinrich Dickel; Burkhard Kreft; Oliver Kuss; Margitta Worm; Stephanie Soost; Jochen Brasch; Wolfgang Pfützner; Jürgen Grabbe; Irena Angelova-Fischer; Peter Elsner; Joachim Fluhr; Peter Altmeyer; Johannes Geier
Journal:  Contact Dermatitis       Date:  2010-05       Impact factor: 6.600

3.  Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations.

Authors:  W Aberer; A Bircher; A Romano; M Blanca; P Campi; J Fernandez; K Brockow; W J Pichler; P Demoly
Journal:  Allergy       Date:  2003-09       Impact factor: 13.146

4.  Diagnosing nonimmediate reactions to cephalosporins.

Authors:  Antonino Romano; Francesco Gaeta; Rocco Luigi Valluzzi; Cristiano Caruso; Cristiana Alonzi; Marinella Viola; Philippe Jean Bousquet
Journal:  J Allergy Clin Immunol       Date:  2012-02-08       Impact factor: 10.793

5.  The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity.

Authors:  B Nyfeler; W J Pichler
Journal:  Clin Exp Allergy       Date:  1997-02       Impact factor: 5.018

6.  Natural evolution of skin test sensitivity in patients allergic to beta-lactam antibiotics.

Authors:  M Blanca; M J Torres; J J García; A Romano; C Mayorga; E de Ramon; J M Vega; A Miranda; C Juarez
Journal:  J Allergy Clin Immunol       Date:  1999-05       Impact factor: 10.793

7.  Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption.

Authors:  Y Kano; K Hirahara; Y Mitsuyama; R Takahashi; T Shiohara
Journal:  Allergy       Date:  2007-12       Impact factor: 13.146

8.  Determining the negative predictive value of provocation tests with beta-lactams.

Authors:  P Demoly; A Romano; C Botelho; L Bousquet-Rouanet; F Gaeta; R Silva; G Rumi; J Rodrigues Cernadas; P J Bousquet
Journal:  Allergy       Date:  2009-10-26       Impact factor: 13.146

9.  Hypersensitivity reactions to drugs: correlation between clinical probability score and laboratory diagnostic procedures.

Authors:  T Pérez; E Dayer; J P Girard
Journal:  J Investig Allergol Clin Immunol       Date:  1995 Sep-Oct       Impact factor: 4.333

Review 10.  Cellular in vitro diagnosis of adverse drug reactions.

Authors:  Christian Möbs; Wolfgang Pfützner
Journal:  Allergo J Int       Date:  2014-08-07
View more
  1 in total

Review 1.  [Personalized medicine in allergology].

Authors:  W Pfützner; J Pickert; C Möbs
Journal:  Hautarzt       Date:  2019-01       Impact factor: 0.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.